Request a copy of the file
Enter the following information to request a copy for the following item: Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Requesting the following file: 2022_Foley_Lancet_Neurol.pdf